Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Exposure to fine particulate matter can trigger cardiovascular deaths, heart attacks

Exposure to fine particulate matter can trigger cardiovascular deaths, heart attacks

Stereotaxis reports $10.6 million revenue for first-quarter 2010

Stereotaxis reports $10.6 million revenue for first-quarter 2010

Abbott's SPIRIT IV trial results published in The New England Journal of Medicine

Abbott's SPIRIT IV trial results published in The New England Journal of Medicine

CSI fiscal third-quarter revenue increases 9% to $16.5 million

CSI fiscal third-quarter revenue increases 9% to $16.5 million

TCT for Surgeons to showcase hybrid surgical, interventional techniques during TCT 2010

TCT for Surgeons to showcase hybrid surgical, interventional techniques during TCT 2010

Animal study shows insulin prevents artery damage

Animal study shows insulin prevents artery damage

Data from Phase IV study of Bystolic tablets in Hispanic patients with hypertension presented at ASH 2010

Data from Phase IV study of Bystolic tablets in Hispanic patients with hypertension presented at ASH 2010

Researchers use healthy person's complete genome sequence to predict risk for dozens of diseases

Researchers use healthy person's complete genome sequence to predict risk for dozens of diseases

MicroStockProfit.com releases investment report featuring Cardium Therapeutics

MicroStockProfit.com releases investment report featuring Cardium Therapeutics

Coronary artery calcium score helpful for determining intermediate risk of heart disease

Coronary artery calcium score helpful for determining intermediate risk of heart disease

Cedars-Sinai Heart Institute presents new findings on heart transplantation rejection factors

Cedars-Sinai Heart Institute presents new findings on heart transplantation rejection factors

Complete revascularization reduces mortality rate in CAD patients

Complete revascularization reduces mortality rate in CAD patients

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

Study: 28.8% of CAD patients who fails to undergo complete revascularization face higher mortality rate

Study: 28.8% of CAD patients who fails to undergo complete revascularization face higher mortality rate

Study finds no decrease in access to medical care for sicker patients needing CABG surgery

Study finds no decrease in access to medical care for sicker patients needing CABG surgery

Coronary CTA can be alternative, non-invasive diagnostic imaging test to triage CAD patients: Study

Coronary CTA can be alternative, non-invasive diagnostic imaging test to triage CAD patients: Study

Tryton Medical widens European availability of Side Branch Stent System

Tryton Medical widens European availability of Side Branch Stent System

Non-invasive coronary CTA cost-effective alternative to invasive cardiac catheterization for CAD evaluation

Non-invasive coronary CTA cost-effective alternative to invasive cardiac catheterization for CAD evaluation

Framingham risk assessment tool fails to predict patients with suspected CAD: Study

Framingham risk assessment tool fails to predict patients with suspected CAD: Study

Modest weight reduction reverses immune cell damage in obese people with diabetes

Modest weight reduction reverses immune cell damage in obese people with diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.